Article info

Download PDFPDF
Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation
  1. Martijn J J Finken, Department of Pediatrics, Leiden University Medical Center, P. O. Box 9600, 2300 RC Leiden, The Netherlands; m.j.j.finken{at}lumc.nl
View Full Text

Citation

Finken MJJ, Keijzer-Veen MG, Dekker FW, et al
Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation

Publication history

  • Accepted March 25, 2008
  • First published May 1, 2008.
Online issue publication 
October 26, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.